Coronary Artery Calcium for Personalized Risk Management—A Second Chance for Aspirin in Primary Prevention?

Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019

(2020) Miguel Cainzos-Achirica et al.   CIRCULATION

Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease

(2020) Ezimamaka Ajufo et al.   JAMA Cardiology

The rise and fall of aspirin in the primary prevention of cardiovascular disease

(2019) Inbar Raber et al.   LANCET

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

(2019) Hertzel C Gerstein et al.   LANCET

Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease

(2019) Guillaume Marquis-Gravel et al.   CIRCULATION

Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis

(2014) Michael D. Miedema et al.  

Dyslipidemia, Coronary Artery Calcium, and Incident Atherosclerotic Cardiovascular Disease

(2013) Seth S. Martin et al.   CIRCULATION

Potential Implications of Coronary Artery Calcium Testing for Guiding Aspirin Use Among Asymptomatic Individuals With Diabetes

(2012) M. G. Silverman et al.   DIABETES CARE